pharma&

pharma& is a privately owned global company with a focus on breathing new life into proven medicines. Established in 2017, the company is dedicated to preserving the availability and fostering the further development of essential medicines worldwide to leave no patient behind.

Over the past five years, pharma& has made significant strides in expanding its portfolio, having acquired and integrated 10+ medicines across various therapy areas, with a pronounced emphasis on hematology and oncology treatments.

The innovative approach of the Company, leveraging a unique synthesis of subsidiaries, joint ventures, and partners, has enabled pharma& to provide its portfolio of medicines to eligible patients worldwide. This is achieved by spanning the continuum of development, product and API manufacturing, partner distribution, healthcare provider engagement, as well as distribution and services to patients.

pharma& operates within the Health Care, Health and Wellness, Manufacturing, and Pharmaceutical industries. As of the latest available information, there is no specific detail regarding the headquarters, last investment, or last investment investors of the company.